Biotechnology at Claflin University

A bachelor's in biotechnology from Claflin carries an estimated debt load of $24,125—above the national median for similar programs—while first-year earnings estimates from peer programs nationwide suggest around $47,000. That 0.51 debt-to-earnings ratio isn't alarming, but it's worth noting that with 73% of students receiving Pell grants, many families here are making this investment with limited financial cushion. The debt figure exceeds what typical biotech programs produce nationally, which matters when you're banking on entry-level science wages to manage repayment.

The challenge is that we're working entirely with estimates here since Claflin's graduate cohort is too small for the Department of Education to report actual outcomes. Comparable biotech programs nationally show considerable variation—the 75th percentile reaches $51,658 while others lag behind—and we simply don't know where Claflin's graduates land within that range. As South Carolina's only reported biotech bachelor's program in this dataset, there's no in-state comparison to gauge regional employment prospects either.

For families considering this program, the financial picture hinges on unknowns: whether Claflin's graduates match national norms, whether local biotech employers actively recruit here, and whether graduate school—common in this field—is part of the plan. The estimated numbers suggest manageability if earnings materialize as projected, but you're making this decision without the actual track record that larger programs can demonstrate.